TRANSENTERIX INC.·4

Dec 10, 7:40 PM ET

TRANSENTERIX INC. 4

4 · TRANSENTERIX INC. · Filed Dec 10, 2013

Insider Transaction Report

Form 4
Period: 2013-12-06
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2013-12-06866,234.40 total(indirect: By Synergy Life Science Partners LP)
    Common Stock (8,662,344 underlying)
  • Conversion

    Common Stock

    2013-12-06$0.40/sh+8,662,344$3,464,93825,487,597 total(indirect: By Synergy Life Science Partners, L.P.)
Holdings
  • Common Stock

    (indirect: By Synecor, L.L.C.)
    1,960,610
Footnotes (3)
  • [F1]Synergy Venture Partners, LLC ("SVP LLC") serves as the sole General Partner of Synergy Life Science Partners, LP ("Synergy"). Mr. Stack is a Manager of SVP LLC and shares voting and dispositive power over the shares held by Synergy. Mr. Stack disclaims beneficial ownership of the shares of the issuer held by Synergy, except to the extent of his or its proportionate pecuniary interest therein.
  • [F2]The Reporting Person is a managing member of Synecor, L.L.C. ("Synecor"). The Reporting Person disclaims beneficial ownership of the shares held by Synecor except to the extent of his proportionate pecuniary interest therein.
  • [F3]Upon the filing of the Issuer's Amended and Restated Certificate of Incorporation on December 6, 2013, each issued and outstanding share of Series B Convertible Preferred Stock automatically converted into ten (10) shares of the Issuer's common stock. The Series B Convertible Preferred Stock has no expiration date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION